Inquiry Basket
Loading ......
Creative Diagnostics Anti-VSV Hybridomas provide a reliable and high-performance solution for the production of monoclonal antibodies targeting vesicular stomatitis virus (VSV).The hybridomas use advanced hybridoma technology with optimized screening systems to produce cells that show high sensitivity and specificity and reproducibility. Each hybridoma undergoes complete validation to ensure reliable operation and stable performance and precise viral antigen detection. The application of Anti-VSV Hybridomas extends to virology research and vaccine development and antiviral drug discovery and diagnostic assay establishment for infectious disease research and immune response analysis and therapeutic innovation.
Creative Diagnostics offers Anti-VSV Hybridomas for highly sensitive and specific detection of vesicular stomatitis virus (VSV) antigens in biological samples.The researchers developed hybridomas through advanced hybridoma technology before performing quality control validation to achieve precise and reliable results. The viruses are used in viral detection, VSV pathogenesis studies, immune response analysis, vaccine development and antiviral research. Our product advantages:
The production of monoclonal antibodies with high specificity and sensitivity against vesicular stomatitis virus (VSV) antigens becomes possible through the combination of advanced hybridoma technology and validated screening systems in these cell lines. The hybridoma cells receive complete quality control evaluation to verify their growth performance and antibody production stability and consistent output. The validation process includes testing antigen specificity and antibody yield and lot-to-lot consistency to guarantee reliable results for research and practical applications. The application of Anti-VSV Hybridomas extends to various fields including viral detection and pathogenesis studies as well as immune response investigations and vaccine creation and antiviral drug development. The Anti-VSV Hybridoma service delivers high-quality antibody production through its strict quality standards and deep hybridoma development expertise which results in reliable experimental results.
| Cat_N | Product Name | |
| CSC-H0001LN | Anti-VSV-G Hybridoma [9H6G22] | Inquiry |
| CSC-H0002LN | Anti-VSV-N Hybridoma [21H5] | Inquiry |
| CSC-H0003LN | Anti-VSV-G Hybridoma [JF10G10] | Inquiry |
| CSC-H0004LN | Anti-VSV-M Hybridoma [34H23] | Inquiry |
ELISA was performed with monoclonal antibodies generated from Anti-VSV Hybridomas to detect various concentrations of VSV antigens. Curves represent three different production batches, demonstrating high reproducibility, batch-to-batch consistency, and strong sensitivity of the hybridoma-derived antibodies.
Application of Anti-VSV Hybridomas in Viral Pathogenesis Research
Background:
The vesicular stomatitis virus (VSV) functions as a vital model virus for scientists to study viral replication mechanisms and immune system reactions and antiviral intervention methods. The detection of VSV antigens with precision serves as a vital tool to track disease progression and assess the effectiveness of experimental treatments.
Objective:
The study examines VSV entry into mammalian cells grown in laboratory settings and tests antiviral drug effectiveness.
Methods:
Scientists employed Anti-VSV Hybridomas to produce monoclonal antibodies which specifically bind to VSV glycoproteins. The antibodies underwent testing through immunofluorescence assays and Western blotting and ELISA to monitor viral protein expression at multiple time points. The hybridoma cell lines produced antibodies at a constant rate during all experimental periods.
Results:
Conclusion:
The Anti-VSV Hybridomas system enabled scientists to conduct VSV research through its precise virus detection and steady antibody production and antiviral treatment monitoring capabilities. The research shows their value for basic virological studies and actual medical treatments.
They're stable cell lines that continuously produce monoclonal antibodies specifically targeting vesicular stomatitis virus (VSV), so you don't have to repeatedly generate new antibodies.
Super reliable! The validation process of each hybridoma cell line ensures that it produces reliable amounts of antibodies which produce identical results in successive production batches.
Absolutely.These cells work well for detecting viruses and studying immune system reactions and vaccine creation and antiviral drug testing.
They grow robustly under standard hybridoma culture conditions.We provide guidance to keep them healthy and producing high-quality antibodies.
Yes!The hybridomas produce antibodies which show both high specificity and low cross-reactivity characteristics that make them suitable for conducting detailed virology research.
Loading ......
